69 Biotech Startups in Switzerland to Watch in 2024
How do we build this list?
Tracking:
Last update to the database: March 25, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Viral vector-based cancer vaccines developer. |
$82M · Series C | Bpifrance, 5AM Ventures, Abingworth | 1 to 10 | Health Tech, Biotech | B2C | Basel, Switzerland | •••••••••••@nouscom.com | |
Antibody discovery and human immune repertoire analysis platform. |
$27M · Series C | Vesalius Biocapital Partners, Adjuvant Capital, Swisscanto Private Equity | 11 to 50 | Health Tech, Biotech | B2B | Zürich, Switzerland | •••••••••••@memo-therapeutics.com | |
Clinical-stage central nervous system (CNS) technology. |
$110M · Series B | Sofinnova Partners, Forbion Capital Partners, BioMedPartners | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Basel, Switzerland | •••••••••••@noemapharma.com | |
Generative AI platform for protein design and engineering. |
$24M · Series A | Index Ventures, Kindred Capital | 11 to 50 | AI, Biotech | B2B | Zürich, Switzerland | •••••••••••@cradle.bio | |
Small molecule mitophagy inducers developer. |
$20M · Series A | ND Capital | 1 to 10 | Health Tech, Biotech | Lausanne, Switzerland | •••••••••••@vandria.com | ||
Gene therapy research to tackle genetic diseases. |
$59M · Series A | Gimv | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@anjarium.com | |
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat and rehab patients. |
$125M | Hambro Perks Ltd. | 101 to 250 | Health Tech, AR / VR, Biotech, Deep Tech, Business Intelligence | B2B | Lausanne, Switzerland | •••••••••••@mindmaze.com | |
Precision medicine developer for neuropsychiatric and neurological disorders. |
$13M · Series B | SPRIM Global Investments | 11 to 50 | Biotech | Geneva, Switzerland | •••••••••••@stalicla.com | ||
Developer of small molecules to treat novel drug resistance pathways in cancer therapy. |
$20M · Series A | BioMedPartners, Altos Ventures, Redalpine | 1 to 10 | Health Tech, Biotech | Zürich, Switzerland | •••••••••••@tolremo.com | ||
Self-adjuvanting and multi-antigen vaccine technology platform. |
$3M · Series A | Novo A/S, Adjuvant Capital, Repair Impact Fund | 11 to 50 | Health Tech, Biotech | Zürich, Switzerland | •••••••••••@lmtbio.com | ||
RNA sequencing and transcriptomics analysis platform. |
$3M · Seed | Novalis Biotechnology Incubation, TechU Ventures, Foundation for Technological Innovation (FIT) | 1 to 10 | Health Tech, Biotech | B2B | Lausanne, Switzerland | •••••••••••@alitheagenomics.com | |
Novel antiobiotic researcher to fight antimicrobial resistance. |
$8M · Series C | AMR Action Fund | 1 to 10 | Biotech, Pharma | B2B | Basel, Switzerland | •••••••••••@bioversys.com | |
Non-invasive treatment for heart arrhythmias. |
$15M · Series A | EIC Accelerator, Panakes Partners | 1 to 10 | Health Tech, Biotech | B2B | Geneva, Switzerland | •••••••••••@eba-med.com | |
Glycanengineering platform. |
$49M · Series A | Sofinnova Partners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@glycoera.com | |
Nanolive has developed a disruptive proprietary technology. |
$20M | Swisscom Ventures | 1 to 10 | Health Tech, Biotech, Pharma, Manufacturing, Business Intelligence | B2B, SaaS | Lausanne, Switzerland | •••••••••••@nanolive.ch | |
Accurate monitoring and treatment platform for sleep bruxism and sleep apnea. |
$3M · Seed | Zürcher Kantonal Bank, Supermoon Capital, Creadd Ventures | 1 to 10 | Health Tech, Biotech | Lausanne, Switzerland | •••••••••••@aesyra.com | ||
Manufacturer of drugs to combat the effects of ageing. |
$10M · Series A | Prima Materia | 11 to 50 | Health Tech, Biotech | B2C | Lausanne, Switzerland | •••••••••••@epiterna.com | |
Program to increase human lifespan. |
$5M · Seed | Maximon | 11 to 50 | Health Tech, Biotech | B2C | Zug, Switzerland | •••••••••••@biolytica.com | |
Gene and cell therapy manufacturing. |
$50M · Series A | 101 to 250 | Biotech | Lausanne, Switzerland | •••••••••••@newbiologix.com | |||
Microcaps develops a novel technology that enables the scalable production of precise microcapsules and microparticles. |
$5M · Seed | Helvetica Capital | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | Zürich, Switzerland | •••••••••••@microcaps.ch | |
Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies. |
$15M · Seed | Novo A/S, Pureos Bioventures | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | Basel, Switzerland | •••••••••••@engimmune.com | |
Clinical-stage biotechnology developing treatments for cancer. |
$15M · Series B | EIC Accelerator | 11 to 50 | Biotech | Geneva, Switzerland | •••••••••••@ionctura.com | ||
True precision medicine through single-cell science |
$1M · Series A | Verve Ventures, Swisscom Ventures | 11 to 50 | Health Tech, AI, Biotech | B2B | Basel, Switzerland | •••••••••••@scailyte.com | |
Immunotherapy platform for cancer. |
$330k · Pre Seed | Lightspeed Venture Partners, BioMedPartners, Gimv | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@immunostherapeutics.com | |
Planetary uses biomass and precision fermentation techniques to create meat and dairy alternatives. |
$8M · Seed | XAnge, Astanor Ventures, Nucleus Capital | 11 to 50 | Foodtech, Biotech, Manufacturing | B2B | Geneva, Switzerland | •••••••••••@planetarygroup.ch | |
Pharvaris is a clinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients. |
$80M · Series C | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Zug, Switzerland | •••••••••••@pharvaris.com | ||
BC Platforms is a data and technology company providing tools to advance the development of personalized medicine and precision medicine. |
$20M | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma, Data and Analytics, Business Intelligence | B2B, SaaS | Zürich, Switzerland | •••••••••••@bcplatforms.com | ||
Qnami develops quantum sensing technologies designed for nanoscale imaging. |
$2M · Seed | Quantonation, High-Tech Gründerfonds, Verve Ventures | 11 to 50 | Health Tech, Hardware, Biotech, Navigation and Mapping, Manufacturing | B2B | Basel, Switzerland | •••••••••••@qnami.ch | |
Developer of an antibody-drug conjugates (ADCs). |
$110k · Pre Seed | btov Partners, Pureos Bioventures, Redalpine | 1 to 10 | Health Tech, Biotech | B2B | Zürich, Switzerland | •••••••••••@ararisbiotech.com | |
Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics. |
$30M · Series A | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B | Basel, Switzerland | •••••••••••@vectorbiopharma.com | ||
Cimeio Therapeutics develops curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders. |
$50M · Series A | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Basel, Switzerland | •••••••••••@cimeio.com | ||
T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments. |
$26M · Series C | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Basel, Switzerland | •••••••••••@t3pharma.com | ||
Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies. |
$25M · Series A | 1 to 10 | Health Tech, Fintech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@rejuveron.com | ||
Invasight is a clinical biotech company that focused on revolutionizing cell invasion research. |
$4M · Seed | High-Tech Gründerfonds, Verve Ventures | 1 to 10 | Health Tech, Biotech, Deep Tech | B2B | Zürich, Switzerland | •••••••••••@invasight.com | |
Rqmicro develops a pathogen separation and detection technology that delivers accurate results in less than 2 hours |
$6M · Series B | 11 to 50 | Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Business Intelligence | B2B | Zürich, Switzerland | •••••••••••@rqmicro.com | ||
Chord Therapeutics is a clinical stage biopharmaceutical company developing drugs for rare diseases. |
$16M · Series A | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Geneva, Switzerland | •••••••••••@chordtherapeutics.com | ||
Rheon focuses on the development of first-in-class glaucoma drainage devices. |
$6M | 1 to 10 | Health Tech, Hardware, Biotech, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@rheonmedical.com | ||
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs. |
$6M · Seed | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Basel, Switzerland | •••••••••••@versameb.com | ||
Virometix is a privately held biotechnology company developing |
$8M · Series B | 11 to 50 | Health Tech, Biotech | B2B | Zürich, Switzerland | •••••••••••@virometix.com | ||
Navignostics aims to identify the ideal treatment to each cancer patient’s disease. |
$7M | 1 to 10 | Health Tech, Hardware, Biotech, Deep Tech, Pharma | Zürich, Switzerland | •••••••••••@navignostics.com | |||
Antibiotic resistance test. |
$9M · Series B | 1 to 10 | Biotech, Deep Tech | Basel, Switzerland | •••••••••••@resistell.com | |||
Medical robotics company. |
$12M · Series A | 11 to 50 | Biotech | Zürich, Switzerland | •••••••••••@nanoflexrobotics.com | |||
Next-gen IgV therapeutics developer. |
$656k · Pre Seed | High-Tech Gründerfonds | 1 to 10 | Biotech | Basel, Switzerland | •••••••••••@phialogics.com | ||
Molecule is a software platform used to accelerate innovation in the pharmaceutical industry. |
N/A | BACKED VC, Speedinvest, BoxGroup | 11 to 50 | Health Tech, Fintech, Crypto & web3, Biotech, Deep Tech, Pharma | B2B, Marketplace | Schaffhausen, Switzerland | •••••••••••@molecule.to | |
We engineered the first injectable biomaterial that stimulated the body's natural ossification process for rapid bone repair & strengthening |
$166k · Pre Seed | Venture Kick | 1 to 10 | Health Tech, Hardware, Biotech, Deep Tech, Pharma, Manufacturing, ElderTech | B2B | Lausanne, Switzerland | •••••••••••@flowbone.com | |
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and nanofluidics. |
$125k · Pre Seed | Y Combinator, Wingman Ventures | 1 to 10 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@adaptyvbio.com | |
ASPIVIX is developing a device that makes gynecological procedures more comfortable for patients. |
$5M | 1 to 10 | Health Tech, Hardware, Biotech, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@aspivix.com | ||
Clinical stage artificial heart valve. |
$2M · Series A | 1 to 10 | Biotech | B2C | Bern, Switzerland | •••••••••••@novostia.com | ||
MaxWell Biosystems provides solutions to advance basic neuroscience research and accelerate preclinical drug discovery. |
$4M · Series A | 11 to 50 | Health Tech, Biotech, Manufacturing | B2B | Basel, Switzerland | •••••••••••@mxwbio.com | ||
AC BioScience is a biotech company that develops personalized molecular therapies designed for cancer patients. |
$1M · Seed | 11 to 50 | Health Tech, Biotech | B2B | Lausanne, Switzerland | •••••••••••@ac-bioscience.com | ||
Groam provide bio-based and biodegradable foam solutions for fast disposables. |
$161k · Pre Seed | Venture Kick | Agritech, Biotech, Energy & Nuclear, Manufacturing | B2B | Zürich, Switzerland | •••••••••••@groamtech.com | ||
Testmate Health builds self-testing kits that allow you you skip the waiting room & get results at home in minutes. |
$1M · Seed | Next Ventures | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing | B2B, B2C | Lausanne, Switzerland | •••••••••••@testmatehealth.com | |
Bionomous develops devices that automatically inspect and sort miniature biological entities. |
$166k · Pre Seed | Venture Kick | 1 to 10 | Health Tech, Biotech, Machine Learning, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@bionomous.ch | |
Preclinical-stage oncology platform. |
$1M · Seed | 1 to 10 | Health Tech, Biotech | Basel, Switzerland | •••••••••••@ymmunobio.com | |||
Guided medical devices cardiovascular procedures. |
$4M · Series B | 1 to 10 | Biotech | Zürich, Switzerland | •••••••••••@medyria.com | |||
Compounds for immunotherapy and metabolic diseases. |
$1M · Seed | Plutus Investment Group | 1 to 10 | Biotech | Geneva, Switzerland | •••••••••••@mpc-therapeutics.com | ||
Preventive health technology. |
$4M · Pre Seed | 11 to 50 | Health Tech, Biotech | Basel, Switzerland | •••••••••••@aera.health | |||
Bloom Biorenewables is making biomass a true alternative to petroleum. |
$3M | 1 to 10 | Climate Tech & Green Tech, Biotech, Pharma, Energy & Nuclear, Manufacturing | B2B | Fribourg, Switzerland | •••••••••••@bloombiorenewables.com | ||
NextImmune is a privately held biotechnology company. |
$154k · Pre Seed | Venture Kick | Health Tech, Biotech, Pharma | B2B | Basel, Switzerland | •••••••••••@nextimmune.com | ||
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the nervous system. |
$169k · Pre Seed | Venture Kick | 1 to 10 | Health Tech, Hardware, Biotech, Deep Tech, Manufacturing | B2B | Geneva, Switzerland | •••••••••••@neurosoft-bio.com | |
Galventa Provides Pharmaceutical Manufacturing Services. |
$807k · Seed | 1 to 10 | Health Tech, Biotech, Pharma, Fitness, Manufacturing, Service Industry | B2B | Saint Gallen, Switzerland | •••••••••••@galventa.com | ||
Comphya developing an active implantable medical device to restore the erectile function of patient non-responsive to oral drugs. |
$833k · Pre Seed | 1 to 10 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@comphya.com | ||
Vatorex enhances honey bee health through an effective and practicable hyperthermic system to fight the varroa mite. |
$1M | 1 to 10 | Climate Tech & Green Tech, Agritech, Hardware, Biotech | B2B | Zürich, Switzerland | •••••••••••@vatorex.ch | ||
AI-powered biotech research platform. |
$110k · Pre Seed | 1 to 10 | Biotech, Data and Analytics | B2B, SaaS | Geneva, Switzerland | •••••••••••@aequicens.com | ||
OVOMIND proposes a new way to share and interact with video games by adding a new dimension: Emotions. |
$1M | 1 to 10 | Gaming, Biotech, Data and Analytics, Business Intelligence | B2B, SaaS | Geneva, Switzerland | •••••••••••@ovomind.com | ||
SoHHytec provides renewable system for onsite production of solar fuel and power which is cleaner, greener, and cost-effective. |
$2M · Seed | 1 to 10 | Climate Tech & Green Tech, Biotech, Energy & Nuclear, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@sohhytec.com | ||
Biosimo Chemicals produces sustainable chemicals |
$308k · Pre Seed | 1 to 10 | Biotech, Deep Tech, Proptech & Real Estate, Manufacturing | B2B | Zürich, Switzerland | •••••••••••@biosimo-chemicals.com | ||
The Tokenised Cloud - Sustainable, Decentralised |
$2M · Pre Seed | 11 to 50 | Climate Tech & Green Tech, Health Tech, Crypto & web3, Biotech, Deep Tech, Manufacturing | B2B, SaaS | Zug, Switzerland | •••••••••••@deepsquare.io | ||
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression. |
N/A | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Basel, Switzerland | •••••••••••@cellestia.com |
Sign up to access our full database
Enter your email and get access to 17,000+ technology companies you can partner with.